| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |